论文部分内容阅读
中晚期肝癌的双重供血,特别是门脉供血肿瘤细胞增殖最活跃的肿瘤周边部分的理论,被多数学者证实。故肝癌行肝动脉、门静脉双重化疗是一个值得研究的课题。目前单纯经门脉直接灌注的研究报告不多。我们对31例晚期肝癌病人经皮穿刺门静脉及经脐门静脉插管灌注化疗药物取得了较好
The theory of double blood supply of advanced liver cancer, especially the peripheral part of the tumor with the most active proliferation of portal tumor cells, was confirmed by most scholars. Therefore, hepatic artery and portal vein chemotherapy for hepatocellular carcinoma is a subject worthy of study. At present, there are not many reports on direct portal perfusion. We achieved better results in 31 patients with advanced liver cancer who underwent percutaneous portal vein and transcatheter infusion of chemotherapeutics through the umbilical portal vein.